Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group (Q28141764)
Jump to navigation
Jump to search
scientific article (publication date: 16 September 2000)
Language | Label | Description | Also known as |
---|---|---|---|
English | Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group |
scientific article (publication date: 16 September 2000) |
Statements
Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group (English)
0 references
16 September 2000
0 references
356
0 references
9234
0 references
961-7
0 references